Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP866795.RA-IVRLMhrKmVVQSVxgUYaj4aa3y5YIuDwJq8-W0WqIJs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP866795.RA-IVRLMhrKmVVQSVxgUYaj4aa3y5YIuDwJq8-W0WqIJs130_assertion type Assertion NP866795.RA-IVRLMhrKmVVQSVxgUYaj4aa3y5YIuDwJq8-W0WqIJs130_head.
- NP866795.RA-IVRLMhrKmVVQSVxgUYaj4aa3y5YIuDwJq8-W0WqIJs130_assertion description "[The most frequently mutated genes specify proteins implicated in chromatin remodeling: 44% of the tumors had somatic inactivating mutations in MEN1, which encodes menin, a component of a histone methyltransferase complex, and 43% had mutations in genes encoding either of the two subunits of a transcription/chromatin remodeling complex consisting of DAXX (death-domain-associated protein) and ATRX (? thalassemia/mental retardation syndrome X-linked).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP866795.RA-IVRLMhrKmVVQSVxgUYaj4aa3y5YIuDwJq8-W0WqIJs130_provenance.
- NP866795.RA-IVRLMhrKmVVQSVxgUYaj4aa3y5YIuDwJq8-W0WqIJs130_assertion evidence source_evidence_literature NP866795.RA-IVRLMhrKmVVQSVxgUYaj4aa3y5YIuDwJq8-W0WqIJs130_provenance.
- NP866795.RA-IVRLMhrKmVVQSVxgUYaj4aa3y5YIuDwJq8-W0WqIJs130_assertion SIO_000772 21252315 NP866795.RA-IVRLMhrKmVVQSVxgUYaj4aa3y5YIuDwJq8-W0WqIJs130_provenance.
- NP866795.RA-IVRLMhrKmVVQSVxgUYaj4aa3y5YIuDwJq8-W0WqIJs130_assertion wasDerivedFrom befree-2016 NP866795.RA-IVRLMhrKmVVQSVxgUYaj4aa3y5YIuDwJq8-W0WqIJs130_provenance.
- NP866795.RA-IVRLMhrKmVVQSVxgUYaj4aa3y5YIuDwJq8-W0WqIJs130_assertion wasGeneratedBy ECO_0000203 NP866795.RA-IVRLMhrKmVVQSVxgUYaj4aa3y5YIuDwJq8-W0WqIJs130_provenance.